| Unique targeting of androgen‐dependent and‐independent AR signaling in prostate cancer to overcome androgen resistance SC Lim, PJ Jansson, SJ Assinder, S Maleki, DR Richardson, Z Kovacevic The FASEB Journal 34 (9), 11511-11528, 2020 | 35 | 2020 |
| Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1 B Geleta, FS Tout, SC Lim, S Sahni, PJ Jansson, MV Apte, ... Journal of Biological Chemistry 298 (3), 2022 | 32 | 2022 |
| Overcoming tamoxifen resistance in oestrogen receptor‐positive breast cancer using the novel thiosemicarbazone anti‐cancer agent, DpC SN Maqbool, SC Lim, KC Park, R Hanif, DR Richardson, PJ Jansson, ... British journal of pharmacology 177 (10), 2365-2380, 2020 | 32 | 2020 |
| Site-specific antibody modification and immobilization on a microfluidic chip to promote the capture of circulating tumor cells and microemboli CH Lai, SC Lim, LC Wu, CF Wang, WS Tsai, HC Wu, YC Chang Chemical Communications 53 (29), 4152-4155, 2017 | 26 | 2017 |
| The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer SC Lim, B Geleta, S Maleki, DR Richardson, Ž Kovačević Journal of Biological Chemistry 297 (6), 2021 | 25 | 2021 |
| E6AP promotes a metastatic phenotype in prostate cancer C Gamell, I Bandilovska, T Gulati, A Kogan, SC Lim, Z Kovacevic, ... Iscience 22, 1-15, 2019 | 11 | 2019 |
| Multiomic characterization and drug testing establish circulating tumor cells as an ex vivo tool for personalized medicine JY Chen, HH Chou, SC Lim, YJ Huang, KC Lai, CL Guo, CY Tung, CT Su, ... Iscience 25 (10), 2022 | 9 | 2022 |
| Liposome-tethered supported lipid bilayer platform for capture and release of heterogeneous populations of circulating tumor cells PY Yeh, JY Chen, MY Shen, TF Che, SC Lim, J Wang, WS Tsai, CW Frank, ... Journal of Materials Chemistry B 11 (34), 8159-8169, 2023 | 1 | 2023 |
